论文部分内容阅读
目的:研究并且探讨盐酸利托君和硫酸镁相配合医治早产胎膜出现早破效果。方法:选择该院2013年2~11月期间早产胎膜出现早破的48例患者实行研究,并将其分成研究组与对照组,每组24例。对照组选择硫酸镁对患者实行医治,研究组则选择盐酸托利君和硫酸镁相配合实行医治。观察并对比两组医治的效果。结果:研究组不仅在总体有效率上比对照组高(P<0.05),且医治、孕龄延长与宫缩抑制的时间均优于对照组,差异在统计学上有意义(P<0.01);但两组不良反应相对比差异在统计学上没有意义(P>0.05)。结论:对于早产胎膜出现早破的患者选择盐酸利托君和硫酸镁配合医治,不但医治效果良好,而且不良反应轻微,值得在临床中推广及应用。
OBJECTIVE: To study and investigate the effect of premature rupture of membranes in the treatment of premature rupture of membranes with the combination of ritodrine hydrochloride and magnesium sulfate. METHODS: Forty-eight patients with premature rupture of membranes in preterm labor from February 2013 to November 2013 were selected and divided into study group and control group, with 24 cases in each group. The control group choose magnesium sulfate for treatment of patients, the study group was selected Tolliodihydrochloride and magnesium sulfate in conjunction with the implementation of treatment. Observed and compared the effect of two groups of treatment. Results: The study group was higher than the control group (P <0.05), and the treatment, gestational age and duration of uterine contractions were better than the control group (P <0.01) However, the relative difference in adverse reactions between the two groups was statistically insignificant (P> 0.05). Conclusion: For premature rupture of membranes in patients with premature rupture of the choice of hydrochloride and magnesium sulfate combined with medical treatment, not only the treatment effect is good, and minor adverse reactions, it is worth in the clinical promotion and application.